Insights from 2024 ASCO® GU Annual Meeting


 

ASCO® GU 2024 Insights: "PROMPT-2 Trial - PSA Response Among Patients With mCSPC Initiated on Apalutamide or Abiraterone Acetate in Real-World Urology Practices"

211 views
February 9, 2024
Comments 0
Login to view comments. Click here to Login